Ung thư tuyến giáp phối hợp đồng thời với cường giáp

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Trung Vinh Hoàng

Ngôn ngữ: Vie

Ký hiệu phân loại: 616.994 +Cancers

Thông tin xuất bản: Tạp chí Nội tiết và Đái tháo đường 2022

Mô tả vật lý: 58-63

Bộ sưu tập: Metadata

ID: 395411

Thêm vào giỏ Liên kết toàn văn

Một số thông báo cho thấy ung thư tuyến giáp (KTG) gặp với tỷ lệ từ 0,76% đến 8,7% trong các loại bướu tuyến giáp (TG) khác nhau đã được điều trị cường giáp (CG). Mặc dù đã có những thông báo về sự phối hợp ở tỷ lệ cao KTG với CG song cũng có những nghiên cứu trước đây lại nhấn mạnh về sự ít tương thích của hai bệnh này. Có nhiều tranh luận, bàn cãi xung quanh diễn biến KTG phối hợp đồng thời với CG. Belfiore và Ozaki đã nêu: Khi KTG phối hợp với bệnh Grave sẽ có diễn biến theo kiểutương hỗ, tấn công nhau. Một số tác giả khác lại có quan điểm trái ngược cho rằng sự phối hợp 2 bệnh trên không có đặc tính tương hỗ, tấn công nhau. Sự phối hợp của 2 bệnh có thể liên quan đến yếu tố địa lý, chủng tộc và một số yếu tố khác chưa xác định rõ. Để có khái niệm rõ hơn về sự phối hợp của KTG với CG, chúng tôi xin cung cấp những dữ liệu của bệnh nhân (BN) phối hợp đồng thời KTG và CG trên các khía cạnh như biểu hiện lâm sàng, điều trị, kết cục và yếu tố tiên lượng di căn của bệnh., Tóm tắt tiếng anh, It has been reported that thyroid cancer occurs in 0.76% to 8.7% of the glands removed for treatment of thyrotoxicosis. Although recent reports have found higher rates of thyroid cancer associated with hyperthyroidism, earlier reports emphasize the rarity of these 2 conditions occurring simultaneously. Controversy surrounds the disease course of thyroid cancer with concurrent hyperthyroidism. Belfiore et al and Ozaki et al have reported that thyroid cancer associated with Graves disease had an aggressive course. In contrast, other investigators did not highlight the aggressive characteristics. The discrepancies of the results are probably due to geographic, racial, or other unknown factors. To better understand the association of thyroid cancer with hyperthyroidism, we retrospectively reviewed the data of patients who had thyroid cancer with concurrent hyperthyroidism. In the present study, clinical manifestations, treatment, outcome, and factors predicting metastases are presented.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR